Nebivolol | Search Results | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Search Results for 'Nebivolol'

COVID-19: Novel Treatment Protocols using Approved drugs vs Standard of Care vs Vaccine and Antiviral new drug discovery and development – An LPBI Group Response and An LPBI Group & Affiliates Response

Posted in Coronavirus Gene Expression, COVID-19, Population Health Management, Genetics & Pharmaceutical, SARS-CoV-2, Serology tests for coronavirus antibodies, Treatment Protocols for COVID-19, Vaccinology, Virus Infective Acute Respiratory Syndrome: SARS-CoV on May 29, 2020| Leave a Comment »

COVID-19: Novel Treatment Protocols using Approved drugs vs Standard of Care vs Vaccine and Antiviral new drug discovery and development – An LPBI Group Response and An LPBI Group & Affiliates Response Curator: Aviva Lev-Ari, PhD, RN On 5/26/2020 LPBI organized a Symposium on New Therapeutics for COVID-19 AGENDA included presentations by: Dr. Raphael […]

Read Full Post »

Clinical Trial for the Use of Nitric Oxide to Treat Severe COVID-19 Infection

Posted in COVID-19, FDA Regulatory Affairs, Frontiers in Cardiology and Cardiovascular Disorders, Nitric Oxide in Health and Disease, Population Health Management, Population Health Management, Genetics & Pharmaceutical, SARS-CoV-2, Virus Infective Acute Respiratory Syndrome: SARS-CoV on April 14, 2020| 3 Comments »

Clinical Trial for the Use of Nitric Oxide to Treat Severe COVID-19 Infection Reporter and Curator: Aviva Lev-Ari, PhD, RN UPDATED 5/26/2020 Virology . 2009 Dec 5;395(1):1-9. doi: 10.1016/j.virol.2009.09.007. Epub 2009 Oct 1. Dual Effect of Nitric Oxide on SARS-CoV Replication: Viral RNA Production and Palmitoylation of the S Protein Are Affected Sara Akerström1, Vithiagaran Gunalan, Choong Tat […]

Read Full Post »

Dynamic Contents for LPBI Group’s PowerPoint Presentation

Posted in on February 17, 2019|

Dynamic Contents for LPBI Group’s PowerPoint Presentation The source material used in the creation of LPBI Group’s PowerPoint Presentation is from Nomination for 2018 Yidan Prize, recognition in the field of MEDICAL education: development of curation methodologies for scientific content – 2018 Nominee, Aviva Lev-Ari, PhD, RN https://pharmaceuticalintelligence.com/2018/10/21/nomination-for-2018-yidan-prize-recognition-in-the-field-of-medical-education-development-of-curation-methodologies-for-scientific-content-2018-nominee-aviva-lev-ari-phd-rn/ WORK-in-PROGRESS Challenges and Opportunities for […]

Read Full Post »

Article Title, Author/Curator’s Name and Article Views >1,000, 4/2012 – 1/2019 @pharmaceuticalintelligence.com

Posted in Academic Publishing, Big Data & Analytics, Curation, Curation methodology, De novo synthesis, Dialectic, Discovery process, Evolutionary cognition, Experimental validation, Explanatory, Historical relevance, LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management, Open Access Journals, Scientific Publishing, Scientist: Career considerations, Technology Advance Assessment of, Theoretic convergence on January 30, 2019| Leave a Comment »

Article Title, Author/Curator’s Name and Article Views >1,000, 4/2012 – 1/2019 @pharmaceuticalintelligence.com Reporter: Aviva Lev-Ari, PhD, RN Expert, Author, Writer’s Initials Name & Bio Roles @LPBI Group LHB Larry Bernstein, MD, FACP, Member of the Board Expert, Author, Writer – All Specialties of Medicine & Pathology Content Consultant to Series B,C,D,E Editor, Series […]

Read Full Post »

Reflections on a Four-phase Career: Aviva Lev-Ari, PhD, RN, March 2018

Posted in Award Nominations, LPBI Group Founder - Aviva Lev-Ari, LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management on March 6, 2018| 6 Comments »

Reflections on a Four-phase Career: Aviva Lev-Ari, PhD, RN, March 2018 Prepared for publication in American Friends of the Hebrew University (AFHU), May 2018 Newsletter, Hebrew University’s HUJI Alumni Spotlight Section. The profile was up on 5/3/2018 on AFHU website under the Alumni Spotlight at https://www.afhu.org/ Excerpts were Published in AFHU e-news on 5/11/2018. https://us10.campaign-archive.com/?u=5c25136c60d4dfc4d3bb36eee&id=757c5c3aae&e=d09d2b8d72 https://www.afhu.org/2018/05/03/aviva-lev-ari/ Aviva Lev-Ari, PhD, RN – February […]

Read Full Post »

2021 LPBI Plan for IT Projects & Research Projects – LPBI’s TASKS for Research Assistants & Associates

Posted in on May 2, 2019|

2021 LPBI Plan for IT Projects & Research Projects – LPBI’s TASKS for Research Assistants & Associates UPDATED ON 7/16/2021 Project #1: INDEXING all Content for Blockchain Migration per a schema designed by a Vendor in the blookchain space Project #2: How to start a New Website connected to PharmaceuticalIntelligence.com Spanish BioMed e-Series – New […]

Read Full Post »

Data Science is the Greatest Science! It is the Greatest Science for Women, as well

Posted in Big Data & Analytics, Data Science, Scientist: Career considerations, Women in Life Sciences on March 12, 2018| 1 Comment »

Data Science is the Greatest Science! It is the Greatest Science for Women, as well Curator: Aviva Lev-Ari, PhD, RN UPDATED ON 3/2/2018 The Growing Influence of Analytics on the C-Suite This curation has three parts: Part 1: Account of a Data Scientist, Aviva Lev-Ari, PhD – worked in Data Science, 1976-2005 […]

Read Full Post »

CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018

Posted in Conference Coverage with Social Media, Drug Delivery Platform Technology, Drug Development Process, Drug Discovery Chemistry, Personalized and Precision Medicine & Genomic Research, Pharmaceutical Analytics, Pharmaceutical Discovery, Pharmaceutical Drug Discovery, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Informatics, Pharmaceutical R&D Investment, Pharmacodynamics and Pharmacokinetics, Pharmacogenomics, Pharmacologic toxicities on February 21, 2018| Leave a Comment »

CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018 Reporter: Aviva Lev-Ari, PhD, RN ANNOUNCEMENT Leaders in Pharmaceutical Business Intelligence (LPBI) Group is a selected CHI Business Partner for Media Communication for this event as well a provider of REAL TIME PRESS COVERAGE for this cardinal event in the domain of Drug Discovery and Drug Delivery. Dr. Aviva […]

Read Full Post »

Updated on 4/14/2019 –>> FIVE years of e-Scientific Publishing @pharmaceuticalintellicence.com, Top Articles by Author and by e-Views >1,000, 4/27/2012 to 1/29/2018

Posted in LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management on April 28, 2017| Leave a Comment »

Updated on 4/14/2019 –>> FIVE years of e-Scientific Publishing @pharmaceuticalintellicence.com, Top Articles by Author and by e-Views >1,000, 4/27/2012 to 1/29/2018 UPDATED on 4/14/2019 Top Posts for all days ending 2019-04-14 (Summarized) All Time Title Views Home page / Archives 615,383 Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century […]